Michelle Mello Stanford

Michelle Mello, JD, PhD

  • Professor, Health Policy
  • Professor, Law
(650) 725-3894 (voice)

Biography

Michelle Mello is Professor of Law at Stanford Law School and Professor of Health Policy in the Department of Health Policy at Stanford University School of Medicine.  She conducts empirical research into issues at the intersection of law, ethics, and health policy.  She is the author of more than 230 articles on medical liability, public health law, the public health response to COVID-19, pharmaceuticals and vaccines, biomedical research ethics and governance, health information privacy, and other topics.
 
The recipient of a number of awards for her research, Dr. Mello was elected to the National Academy of Medicine at the age of 40.  From 2000 to 2014, she was a professor at the Harvard School of Public Health, where she directed the School’s Program in Law and Public Health.
 
Dr. Mello teaches courses in torts, public health law, and health policy.  She holds a J.D. from the Yale Law School, a Ph.D. in Health Policy and Administration from the University of North Carolina at Chapel Hill, an M.Phil. from Oxford University, where she was a Marshall Scholar, and a B.A. from Stanford University. 

In The News

Getty Images Illustration of AI in Health Care
Commentary

Using Artificial Intelligence Tools and Health Insurance Coverage Decisions

cover link Using Artificial Intelligence Tools and Health Insurance Coverage Decisions
Illustration of COVID vaccine and judge's gavel
News

States Adopt Dangerous Legal Reforms Undercutting Public Health Emergency Powers

Michelle Mello and colleagues argue that state legal reforms have exacerbated rather than improved weaknesses in U.S. emergency powers revealed by COVID-19, jeopardizing future responses.
cover link States Adopt Dangerous Legal Reforms Undercutting Public Health Emergency Powers
Michelle Mello testifies before U.S. Senate Committee on Finance
News

Michelle Mello Testifies Before U.S. Senate on AI in Health Care

In her testimony before the U.S. Senate Finance Committee, Mello emphasized the need for federal guardrails and standards regarding the use of artificial intelligence in health care.
cover link Michelle Mello Testifies Before U.S. Senate on AI in Health Care